Epidemiology of Guillain-Barré Syndrome in Iranian Children Aged 0-15 Years (2008-2013)

Seyed Hassan Tonekaboni1, Sussan Mahmoudi2, Fatemeh Abdollah Gorji3

  • 1Pediatrics Neurology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

Guillain-Barré Syndrome (GBS) affects Iranian children, with the highest incidence in those aged 0-5 years. This study highlights the need for health system attention due to GBS treatment costs and potential mortality.

Area of Science:

  • Neurology
  • Epidemiology
  • Pediatrics

Background:

  • Guillain-Barré Syndrome (GBS) is a leading cause of acute flaccid paralysis (AFP) globally.
  • GBS presents as rapid, progressive, symmetric weakness, an acute inflammatory polyneuropathy.

Purpose of the Study:

  • To investigate the epidemiological characteristics of Guillain-Barré Syndrome in Iranian children.
  • To understand the incidence and patterns of GBS in a pediatric population in Iran.

Main Methods:

  • Utilized data from Iran's national Acute Flaccid Paralysis (AFP) surveillance system (2008-2013).
  • Included demographic data from children aged 0-15 years.
  • Employed Chi-square and Fisher's exact tests for statistical analysis.

Main Results:

  • Identified 1884 GBS cases over the study period.
  • Reported an average annual incidence rate of 1.72 per 100,000 individuals.
  • Observed the highest incidence rates in children aged 0-5 years, with no significant seasonal variation.

Conclusions:

  • Approximately 300 new GBS cases annually necessitate focused health system attention.
  • The significant morbidity, mortality, and treatment costs associated with GBS underscore its public health importance.
  • Further research into GBS epidemiology in children is warranted.
Abstract

Related Concept Videos